Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.
Topic Contents
Hypertrophic Cardiomyopathy: Risk of Sudden Death
Overview
Some people who have hypertrophic cardiomyopathy are at high risk for sudden death. It can occur at any age, but it is most shocking when it happens to young adults or athletes. While the media often highlight these tragic deaths, sudden death is rare. It occurs in about 1 out of 100 adults with hypertrophic cardiomyopathy each year.footnote 1
Sudden death is often the result of ventricular tachycardia (a type of rapid heart rate) or other dangerous arrhythmias, which can be caused by hypertrophic cardiomyopathy.
To find out your risk of sudden death, your doctor will do tests and ask you about your health and family history. Your doctor might check to see if you:footnote 2, footnote 3
- Have had cardiac arrest or ventricular tachycardia in the past.
- Had a close relative who had hypertrophic cardiomyopathy and died suddenly.
- Have fainted (syncope).
- Have had low blood pressure during or after exercise.
- Have extreme left ventricle thickness (more than 30 millimeters).
If you are at high risk for sudden death, an implantable cardioverter-defibrillator (ICD) might be right for you. An ICD can identify life-threatening arrhythmias and successfully restore a normal heartbeat.
Because of the possible increased risk of sudden death, it may be a good idea for family members of people who have hypertrophic cardiomyopathy to learn CPR (cardiopulmonary resuscitation).
Related Information
References
Citations
- Maron BJ, Olivotto I (2015). Hypertrophic cardiomyopathy. In DL Mann et al., eds., Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 10th ed., vol. 2, pp. 1574–1588. Philadelphia: Saunders.
- Gersh BJ, et al. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 124(24): e783–e831.
- Al-Khatib SM, et al. (2017). 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation, published online October 30, 2017. DOI: 10.1161/CIR.0000000000000549. Accessed November 6, 2017.
Credits
Current as of: September 7, 2022
Author: Healthwise Staff
Medical Review:
Rakesh K. Pai MD, FACC - Cardiology, Electrophysiology
Martin J. Gabica MD - Family Medicine
Adam Husney MD - Family Medicine
George Philippides MD - Cardiology
- Top of the page
Next Section:
Related Information
Previous Section:
Overview- Top of the page
Next Section:
References
Previous Section:
Related Information- Top of the page
Next Section:
Credits
Previous Section:
References- Top of the page
Current as of: September 7, 2022
Author: Healthwise Staff
Medical Review:Rakesh K. Pai MD, FACC - Cardiology, Electrophysiology & Martin J. Gabica MD - Family Medicine & Adam Husney MD - Family Medicine & George Philippides MD - Cardiology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use and Privacy Policy. Learn how we develop our content.
To learn more about Healthwise, visit Healthwise.org.
© 1995-2023 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.